BioCentury
ARTICLE | Clinical News

Brain-derived neuro-trophic factor: Phase III study of BDNF being conducted in the U.S. and Canada

January 15, 1996 8:00 AM UTC

Amgen Inc. (AMGN), Thousand Oaks, Calif. Regeneron Pharmaceuticals Inc. (REGN), Tarrytown, N.Y. Product: Brain-derived neuro-trophic factor ( BDNF) Indication: Amytrophic lateral sclerosis Status: A...